journals.plos.org /3 days ago

GPCR-Gαq signaling drives adaptive resistance to MEK inhibition in BRAF-mutant melanoma

by Jingyi Ke, Zi Wang, Zhengyang Guo, Guangshuo Ou, Wei Li Oncogenic BRAFV600E mutations drive constitutive MAPK signaling across various cancers; however, resistance to MEK inhib...

Read source
bioengineer.org /5 days ago

Hypoxia-Driven SPP1 Macrophages Promote Fibrosis and Chemoembolization Resistance in Liver Cancer

Spatial multi-omic profiling reveals that transarterial chemoembolization promotes hypoxia-driven SPP1-positive macrophages that produce fibronectin, build immunosuppressive fibrot...

Read source
healio.com /1 week ago

ANGPTL4 inhibition appears to reduce triglycerides

CHICAGO — A monoclonal antibody that inhibits angiopoietin-like protein 4 was linked to triglyceride reduction at 12 weeks in adults with high triglycerides, researchers reported a...

Read source
healio.com /3 weeks ago

Caring for patients with immunotherapy-related hepatitis

NASHVILLE — In this video, Elliot Tapper, MD, FAASLD, discusses a presentation from the ACG Annual Meeting about when it is safe to stop cancer therapy when it results in hepatitis...

Read source
qchron.com /4 weeks ago

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentati...

PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was reduced by 51% (HR 0.49; 95% CI 0.36-0.65; P

Read source
bioengineer.org /3 weeks ago

Rare EGFR Mutation Shows Primary Resistance to Afatinib in Lung Cancer Case

A case report documents rapid progression and death in a lung cancer patient with a rare EGFR PACC mutation who showed primary resistance to afatinib.

Read source
bioengineer.org /1 month ago

AML epigenetic therapies face network-driven resistance, review finds

A comprehensive review finds that AML cells commonly overcome epigenetic drugs through compensatory chromatin and transcriptional adaptation, favoring biomarker-selected combinatio...

Read source
asianscientist.com /1 month ago

This Molecular Switch Helps Triple-Negative Breast Cancers Resist Treatment

Researchers uncover how the long non-coding RNA Smyca helps triple-negative breast cancer cells repair DNA damage and survive treatment.

Read source
bioengineer.org /1 month ago

Staphylococcal Protein Reprograms Liver Tumor Macrophages to Boost Immunotherapy

One of the most stubborn obstacles in cancer immunotherapy is not the tumor cell itself but the cellular entourage that surrounds it. In hepatocellular carcinoma, the most common f...

Read source
qchron.com /4 weeks ago

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ES...

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89;...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.